Farther Finance Advisors’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Farther Finance Advisors’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-100	Closed	–	–	4721
2025 Q1	$0	Hold	100	–	–	﹤0.01%	4475
2024 Q4	$0	Hold	100	–	–	﹤0.01%	4224
2024 Q3	$0	Hold	100	–	–	﹤0.01%	4172
2024 Q2	$0	Buy	+100	New	–	﹤0.01%	3970

Farther Finance Advisors's KDNY Position: Q2 2025 in Review

Farther Finance Advisors sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q2 2025, closing a stake of 100 shares.

Farther Finance Advisors first reported a position in KDNY in Q2 2024 and held it in 4 quarters. The position peaked at $0 in Q1 2025. 0 funds tracked by Wall St. Rank hold KDNY as of Q2 2025.

Farther Finance Advisors reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
Farther Finance Advisors sold 100 Chinook Therapeutics, Inc. Common Stock shares in Q2 2025.
Farther Finance Advisors first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2024 and held it in 4 quarters.
Farther Finance Advisors's Chinook Therapeutics, Inc. Common Stock position peaked at $0 in Q1 2025.
0 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q2 2025.

Based on Farther Finance Advisors's 13F filing for Q2 2025, filed 11 Jul 2025.